MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2019 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBALSPB |
Anteile |
49.3 M |
Marktkapitalisierung |
$ 3.73 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Aprea Therapeutics
APRE
|
$ 0.5 | -1.96 % | $ 3.27 M | Nasdaq Global Select Market,SPB | USA |
 |
Galectin Therapeutics
GALT
|
$ 2.98 | -14.12 % | $ 190 M | Nasdaq Global Select Market | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
$ 71.75 | -9.43 % | $ 7.45 B | Nasdaq Capital Market,SPB | USA |
 |
Progenity, Inc.
PROG
|
- | -3.47 % | $ 164 M | Nasdaq Global Select Market | USA |
 |
Genprex
GNPX
|
$ 2.09 | -2.34 % | $ 1.95 M | Nasdaq Capital Market | USA |
 |
Strongbridge Biopharma plc
SBBP
|
- | 1.52 % | $ 136 M | Nasdaq Global Select Market | USA |
 |
Innate Pharma S.A.
IPHA
|
$ 1.4 | -1.76 % | $ 125 M | Nasdaq Global Select Market |  France |
 |
Seneca Biopharma, Inc.
SNCA
|
- | -1.19 % | $ 28.7 M | Nasdaq Capital Market | USA |
 |
BioMarin Pharmaceutical
BMRN
|
$ 56.14 | -1.74 % | $ 10.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Matinas BioPharma Holdings
MTNB
|
$ 1.11 | -7.0 % | $ 6.08 M | NYSE American | USA |
 |
Enanta Pharmaceuticals
ENTA
|
$ 10.06 | -5.54 % | $ 215 K | Nasdaq Global Select Market,SPB | USA |
 |
Milestone Pharmaceuticals
MIST
|
$ 0.69 | -10.54 % | $ 73.3 M | Nasdaq Global Select Market |  Canada |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
$ 88.15 | -8.29 % | $ 6.54 B | Nasdaq Global Select Market | USA |
 |
Lipocine
LPCN
|
$ 1.52 | 5.56 % | $ 8.28 M | Nasdaq Global Select Market | USA |
 |
Seres Therapeutics
MCRB
|
$ 2.09 | -2.63 % | $ 18.5 M | Nasdaq Global Select Market | USA |
 |
Madrigal Pharmaceuticals
MDGL
|
$ 400.26 | -0.04 % | $ 8.98 B | Nasdaq Global Select Market,SPB | USA |
 |
CEL-SCI Corporation
CVM
|
$ 1.35 | -2.88 % | $ 10.8 M | NYSE American,SPB | USA |
 |
Inventiva S.A.
IVA
|
$ 3.65 | -5.68 % | $ 218 M | Nasdaq Global Market | France |
 |
MeiraGTx Holdings plc
MGTX
|
$ 8.51 | -9.71 % | $ 684 M | Nasdaq Global Select Market | USA |
 |
Eton Pharmaceuticals
ETON
|
$ 47.29 | -6.76 % | $ 1.27 B | Nasdaq Global Market | USA |
 |
IDEAYA Biosciences
IDYA
|
$ 30.63 | -5.35 % | $ 2.71 B | Nasdaq Global Select Market | USA |
 |
Lantern Pharma
LTRN
|
$ 0.55 | -5.33 % | $ 5.99 M | Nasdaq Global Select Market | USA |
 |
Foghorn Therapeutics
FHTX
|
$ 1.9 | -9.52 % | $ 120 M | Nasdaq Global Market | USA |
 |
Minerva Neurosciences
NERV
|
$ 2.3 | -10.7 % | $ 19.5 M | Nasdaq Global Market | USA |
 |
Kamada Ltd.
KMDA
|
$ 6.89 | -7.14 % | $ 397 M | Nasdaq Global Select Market |  Israel |
 |
Neurocrine Biosciences
NBIX
|
$ 159.9 | -3.7 % | $ 15.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Nanobiotix S.A.
NBTX
|
$ 29.92 | 0.74 % | $ 1.43 T | Nasdaq Global Select Market | France |
 |
Mereo BioPharma Group plc
MREO
|
$ 0.28 | -7.49 % | $ 223 M | Nasdaq Global Select Market |  Britain |
 |
Maravai LifeSciences Holdings
MRVI
|
$ 6.94 | -10.1 % | $ 1 B | Nasdaq Global Select Market | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
$ 1.61 | 8.78 % | $ 585 M | Nasdaq Global Select Market | USA |
 |
Moleculin Biotech
MBRX
|
$ 8.72 | 3.07 % | $ 10.3 M | Nasdaq Global Select Market | USA |
 |
Nurix Therapeutics
NRIX
|
$ 14.83 | -7.02 % | $ 1.29 B | Nasdaq Global Select Market,SPB | USA |
 |
Nkarta
NKTX
|
$ 1.59 | -8.38 % | $ 118 M | Nasdaq Global Select Market | USA |
 |
MacroGenics
MGNX
|
$ 2.24 | -3.25 % | $ 141 M | Nasdaq Global Select Market | USA |
 |
ImmuCell Corporation
ICCC
|
$ 9.88 | -4.77 % | $ 89.2 M | Nasdaq Global Select Market | USA |
|
Nuvation Bio
NUVB
|
$ 4.19 | -11.42 % | $ 1.43 B | NYSE | USA |
 |
Novo Nordisk A/S
NVO
|
$ 40.27 | -4.52 % | $ 179 B | NYSE |  Danmark |
 |
Marker Therapeutics
MRKR
|
$ 0.9 | -11.24 % | $ 13.8 M | Nasdaq Global Market | USA |
 |
NextCure
NXTC
|
$ 5.16 | -12.39 % | $ 14.7 M | Nasdaq Global Select Market | USA |
 |
Olema Pharmaceuticals
OLMA
|
$ 6.89 | -8.62 % | $ 599 M | Nasdaq Global Select Market | USA |
 |
Kymera Therapeutics
KYMR
|
$ 124.88 | -8.34 % | $ 10.6 B | Nasdaq Global Market | USA |
 |
Oragenics
OGEN
|
$ 0.34 | -9.47 % | $ 733 K | NYSE American | USA |
 |
Ovid Therapeutics
OVID
|
$ 2.59 | -5.66 % | $ 337 M | Nasdaq Global Select Market | USA |
 |
Passage Bio
PASG
|
$ 3.44 | -2.14 % | $ 11 M | Nasdaq Global Select Market | USA |
 |
Vaxcyte
PCVX
|
$ 62.47 | -4.89 % | $ 8.5 B | Nasdaq Global Select Market | USA |
 |
Precigen
PGEN
|
$ 4.2 | -16.94 % | $ 1.31 B | Nasdaq Global Select Market | USA |
 |
Phio Pharmaceuticals Corp.
PHIO
|
$ 0.81 | -7.25 % | $ 4.85 M | Nasdaq Capital Market | USA |
 |
Praxis Precision Medicines
PRAX
|
$ 262.42 | -7.85 % | $ 5.91 B | Nasdaq Global Select Market,SPB | USA |
 |
Prelude Therapeutics Incorporated
PRLD
|
$ 3.55 | -12.99 % | $ 273 M | Nasdaq Global Select Market | USA |
 |
ProQR Therapeutics N.V.
PRQR
|
$ 1.34 | -5.32 % | $ 141 M | Nasdaq Global Market |  Niderland |